New drug tested for serious Alcohol-Related liver disease
NCT ID NCT06685692
Summary
This study tested a new drug called ADX-629 to see if it is safe and helpful for adults with moderate alcohol hepatitis, a serious liver inflammation. It was a small, early-stage trial with just 4 participants. The main goal was to check for side effects while participants agreed to stop drinking alcohol during the study.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL HEPATITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bon Secours Liver Institute of Newport News
Richmond, Virginia, 23221, United States
-
Florida Health Sciences Center/Tampa General Hospital/USF
Tampa, Florida, 33606, United States
-
Methodist Specialty and Transplant Hospital
San Antonio, Texas, 78229, United States
-
Synergry Healthcare
Bradenton, Florida, 34209, United States
-
The Liver Institute at Methodist Dallas Medical Center
Dallas, Texas, 75203, United States
-
UDL Clinical Research, LLC
Houston, Texas, 77057, United States
Conditions
Explore the condition pages connected to this study.